An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gabelli Healthcare & WellnessRx Trust Announces the Offering of $40 Million of 4.00% Series E Cumulative Preferred Shares
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
RYE, N.Y.--(BUSINESS WIRE)--
The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) is pleased to announce the issuance of four million 4.00% Series E Cumulative Preferred Shares (“Series E Preferred”) with an aggregate liquidation value of $40 million.
The Series E Preferred is non-callable until December 26, 2024, and has a liquidation preference of $10 per share. Distributions are scheduled to be paid quarterly beginning on December 26, 2021.
The Board of Trustees would like to thank all participants in the offering.
Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. More information regarding this and other information about the Fund is available by calling 800-GABELLI (800-422-3554) or visiting www.gabelli.com.
About The Gabelli Healthcare & WellnessRx Trust
The Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company with $337 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL).
gamco investors, inc. (nyse:gbl) is a well-established provider of investment advisory services to open and closed-end funds, institutional, and private wealth management investors. since mario j. gabelli founded the firm in 1977, gamco has been recognized for its research driven approach to equity investing and our proprietary private market value (pmv) with a catalyst™ stock selection strategy. as of december 31, 2016, the company has $39.7 billion aum, 95% of which is invested in equities, principally through our two registered investment advisers: gamco asset management inc. (“institutional and private wealth management”) and gabelli funds, llc (“funds”). g.distributors, llc (“g.distributors”) acts as an underwriter and distributor for our open-end funds.
